Sutro Biopharma (STRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements ...

Microsoft (MSFT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead ...

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

StoneCo (STNE) delivered earnings and revenue surprises of 9.38% and 1.80%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Newmont (NEM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: UBS Group AG (UBS Quick Quote UBS - Free Report) : This financial holding company has seen the Zacks Consensus Estimate for its ...

ESPN's weekly PPR and IDP fantasy football rankings are an aggregate of our rankers (eight PPR, three IDP). They are Matt Bowen, Mike Clay, Tristan H. Cockcroft, Daniel Dopp, Eric Karabell, Liz ...